Oxidative DNA damage in tissues of pregnant female mice and fetuses caused by the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)

Cancer Letters

Volumn 117, Issue 1, 1997, Pages 87-91

  Sipowicz, Marek A ^a   Amin, Shantu ^b   Desai, Dhimant ^b   Kasprzak, Kazimierz S ^a   Anderson, Lucy M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

NNK; Oxidative DNA damage; Tobacco specific nitrosamine; Transplacental exposure

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; DEOXYGUANOSINE DERIVATIVE; DNA; NITROSAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; FETUS; FETUS (ANATOMY); LIVER; LUNG; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLACENTA; PRENATAL EXPOSURE; PRIORITY JOURNAL; TOBACCO;

ANIMALS; DNA DAMAGE; FEMALE; MATERNAL-FETAL EXCHANGE; MICE; NITROSAMINES; OXIDATION-REDUCTION; PLANTS, TOXIC; PREGNANCY; TOBACCO;

ANIMALIA; NICOTIANA TABACUM;

EID: 0030819949     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00208-5     Document Type: Article

References (32)

1. IARC, Tobacco Smoking, Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, IARC, Lyon, 1986.
2. M. Stjernfeldt, J. Lindsten, K. Berglund, J. Ludvigsson, Maternal smoking during pregnancy and risk of childhood cancer, Lancet 1 (1986) 1350-1352.
3. G. Pershagen, A. Ericson, P. Otterblad-Olausson, Maternal smoking in pregnancy: does it increase the risk of childhood cancer? Int. J. Epidemiol. 21 (1992) 1-5.
4. E.M. John, D.A. Savitz, D.P. Sandler, Prenatal exposure to parents' smoking and childhood cancer, Am. J. Epidemiol. 133 (1991) 123-132.
5. M. Stjernfeldt, K. Berglund, J. Lindsten, J. Ludvigsson, Maternal smoking and irradiation during pregnancy as risk factors for child leukemia, Cancer Detect. Prevent. 16 (1992) 129-135.
6. D. Hoffmann, A. Rivenson, F.L. Chung, S.S. Hecht, Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis, Crit. Rev. Toxicol. 21 (1991) 305-311.
7. S. Preston-Martin, Evaluation of the evidence that tobacco- specific nitrosamines (TSNA) cause cancer in humans, Crit. Rev. Toxicol. 21 (1991) 295-298.
8. L.M. Anderson, S.S. Hecht, D.E. Dixon, L.F. Dove, R.M. Kovatch, S. Amin, D. Hoffmann, J.M. Rice, Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice, Cancer Res. 49 (1989) 3770-3775.
9. E. Correa, P.A. Joshi, A. Castonguay, H.M. Schuller, The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcino-gen in Syrian golden hamster, Cancer Res. 50 (1990) 3435-3438.
10. T.J. Smith, G.D. Stoner, C.S. Yang, Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides, Cancer Res. 55 (1995) 5566-5573.
11. T.J. Smith, Z. Guo, F.P. Guengerich, C.S. Yang, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate, Carcinogenesis 17 (1996) 809-813.
12. S.S. Hecht, Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen, Crit. Rev. Toxicol. 26 (1996) 163-181.
13. P. Leanderson, C. Tagesson, Mineral fibers, cigarette smoke, and oxidative DNA damage, in: B. Halliwell, O.J. Aruoma (Eds.), DNA and Free Radicals, Ellis Horwood, New York, 1993, pp. 293-314.
14. S. Asami, T. Hirano, R. Yamaguchi, Y. Tomioka, H. Itoh, H. Kasai, Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking, Cancer Res. 56 (1996) 2546-2549.
15. F.L. Chung, Y. Xu, Increased 8-oxodeoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridy)-1-butanone, Carcinogenesis 13 (1992) 1269-1272.
16. A.B. Weitberg, D. Corvese, Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines, Clin. Genet. 43 (1993) 88-91.
17. P.M. Kim, P.G. Wells, Genoprotection by UDP-glucurono-syltransferases in peroxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzopyrene, Cancer Res. 56 (1996) 1526-1532.
18. S.S. Hecht, C.B. Chen, M. Dong, R.M. Ornaf, D. Hoffmann, T.C. Tso, Chemical studies on tobacco smoke. Studies on non-volatile nitrosamines in tobacco, Beitr. Tabakforsch. 9 (1977) 1-6.
19. S. Adachi, M. Zeisig, L. Möller, Improvements of analytical method for 8-hydroxydeoxyguanosine in nuclear DNA, Carcinogenesis 16 (1995) 253-258.
20. H. Tjälve, The tissue distribution and the tissue specificity of bioactivation of some tobacco-specific and some other N-nitrosamines, Crit. Rev. Toxicol. 21 (1991) 265-294.
21. A. Castonguay, H. Tjälve, N. Trushin, S.S. Hecht, Perinatal metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in C57BL mice, J. Natl. Cancer Inst. 7 (1984) 1117-1126.
22. D. Lacroix, M. Desrochers, A. Castonguay, A. Anderson, Metabolism of human kidney epithelial cells transfected with rat CYP2B1 cDNA, Carcinogenesis 14 (1993) 1639-1642.
23. G. Eksktrom, M. Ingelman-Sundberg, Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P450 (P450IIe1), Biochem. Pharmacol. 38 (1989) 1313-1319.
24. S. Puntaralo, A.I. Cederbaum, Role of cytochrome P-450 in the stimulation of microsomal production of reactive oxygen species by ferritin, Biochim. Biophys. Acta 1289 (1996) 238-246.
25. J. Chianale, C. Dvorak, D.L. Farmer, L. Michaels, J.J. Gumucio, Cytochrome P-450 gene expression in the functional units of the fetal liver, Hepatology 8 (1988) 318-326.
26. S. Itoh, M. Satoh, Y. Abe, H. Hashimoto, T. Yanagimoto, T. Kamataki, A novel form of mouse cytochrome P450 3A (Cyp3a-16). Its cDNA cloning and expression in fetal liver, Eur. J. Biochem. 226 (1994) 877-882.
27. M. Kitada, T. Kamataki, K. Itahashi, T. Rikihisa, R. Kato, Y. Kanakubo, Purification and properties of cytochrome P-450 from homogenates of human fetal livers, Arch. Biochem. Biophys. 241 (1985) 275-280.
28. J. Hakkola, M. Pasanen, R. Purkunen, S. Saarikoski, O. Pelkonen, J. Maenpaa, A. Rane, H. Raunio, Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver, Biochem. Pharmacol. 48 (1994) 59-64.
29. J. Maenpaa, A. Rane, H. Raunio, P. Honkakoski, O. Pelkonen, Cytochrome P450 isoforms in human fetal tissues related to phenobarbital-inducible forms in the mouse, Biochem. Pharmacol. 45 (1993) 899-907.
30. M. Kitada, T. Kato, S. Ohmori, T. Kamataki, K. Itahashi, F.P. Guengerich, T. Rikihisa, Y. Kanakubo, Immunochemical characterization and toxicological significance of P-450HFLb purified from human fetal livers, Biochim. Biophys. Acta 1117 (1992) 301-305.
31. T. Kato, H. Nakasha, S. Ohmori, T. Kamataki, K. Itahashi, T. Shimada, T. Rikihisa, M. Kitada, Possible occurrence of P450 related to P450HFLb in extrahepatic tissues of human fetuses and its contribution to metabolic activation of promutagens, Mutat. Res. 310 (1994) 73-77.
32. T. Shimada, C.L. Hayes, H. Yamazaki, S. Amin, S.S. Hecht, F.P. Guengerich, T.R. Sutter, Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1, Cancer Res. 56 (1996) 2979-2984.